Back
News
1 min de lecture

[Press Alert] XENOTHERA obtains authorization from ANSM to start the clinical trial of XAV19, its anti Covid treatment

  • contact@xenothera.com
  • Auteur
    contact@xenothera.com
  • Publié
    12 août 2020

Articles récents

[Press Alert] Omicron Variant : positive results for XENOTHERA's XAV-19 antibody

# Download our press information (english version) # Télécharger notre communiqué de...

More

[Press information] XENOTHERA announces the continuation of development of its anti-SARS-CoV-2 antibody.

January 2022. # Download our press information (english version) # Télécharger notre...

More

[ Press Information ]The French biotech XENOTHERA awarded Start-Up of the Year for the Western region.

# Download our press information (english version) # Télécharger notre information presse...

More